These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 28455959)

  • 21. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
    Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
    Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Par-4 mediated Smad4 induction in PDAC cells restores canonical TGF-β/ Smad4 axis driving the cells towards lethal EMT.
    Mohd Faheem M; Rasool RU; Ahmad SM; Jamwal VL; Chakraborty S; Katoch A; Gandhi SG; Bhagat M; Goswami A
    Eur J Cell Biol; 2020 May; 99(4):151076. PubMed ID: 32439219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.
    Chen L; Fu H; Luo Y; Chen L; Cheng R; Zhang N; Guo H
    Cell Death Dis; 2017 Apr; 8(4):e2728. PubMed ID: 28383549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4.
    Wang Z; Chen J; Wang S; Sun Z; Lei Z; Zhang HT; Huang J
    Cell Death Dis; 2022 Jul; 13(7):656. PubMed ID: 35902557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
    Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.
    Smith AL; Iwanaga R; Drasin DJ; Micalizzi DS; Vartuli RL; Tan AC; Ford HL
    Oncogene; 2012 Dec; 31(50):5162-71. PubMed ID: 22286770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
    Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
    Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-497 Modulates Breast Cancer Cell Proliferation, Invasion, and Survival by Targeting SMAD7.
    Liu J; Zhou Y; Shi Z; Hu Y; Meng T; Zhang X; Zhang S; Zhang J
    DNA Cell Biol; 2016 Sep; 35(9):521-9. PubMed ID: 27303812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
    Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
    Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High NR2F2 transcript level is associated with increased survival and its expression inhibits TGF-β-dependent epithelial-mesenchymal transition in breast cancer.
    Zhang C; Han Y; Huang H; Qu L; Shou C
    Breast Cancer Res Treat; 2014 Sep; 147(2):265-81. PubMed ID: 25129343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
    Shi SJ; Wang LJ; Yu B; Li YH; Jin Y; Bai XZ
    Oncotarget; 2015 May; 6(13):11652-63. PubMed ID: 25871474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-β/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer.
    Zhang C; Hao Y; Wang Y; Xu J; Teng Y; Yang X
    Int J Biol Sci; 2018; 14(12):1715-1723. PubMed ID: 30416386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
    Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
    Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
    Park CY; Kim DK; Sheen YY
    Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.